Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Dec 3;31(2):479–485. doi: 10.1158/1055-9965.EPI-21-0946

Figure 1.

Figure 1.

Kaplan-Meier (K-M) curves of multiple myeloma-specific and all-cause mortality by post-diagnosis aspirin use. A. K-M curves of multiple myeloma-specific mortality for the comparison of participants who reported using aspirin after diagnosis compared to participants who reported no aspirin use post-diagnosis. B. K-M curves of all-cause mortality for the comparison of individuals who reported using aspirin after diagnosis compared to participants who reported no aspirin use post-diagnosis.